搜索筛选:
搜索耗时5.2168秒,为你在为你在102,285,761篇论文里面共找到 7 篇相符的论文内容
类      型:
[期刊论文] 作者:Hend Ahmed El-Hadaad,Hanan Ahm, 来源:癌症治疗(英文) 年份:2014
Purpose: To assess the response rate, duration of response and prognostic factors affecting response after low-dose involved-field radiotherapy in patients with...
[期刊论文] 作者:Hend Ahmed E1-Hadaad,Hanan Ahm, 来源:临床肿瘤与癌症研究:英文版 年份:2012
Objective To explore if the addition of adjuvant chemotherapy with paclitaxel and carboplatin to radiotherapy confers an advantage for overall survival(OAS)...
[期刊论文] 作者:Hend Ahmed EI-Hadaad Hanan AHM, 来源:临床肿瘤和癌症研究:英文版 年份:2011
[期刊论文] 作者:Hend Ahmed El-Hadaad Hanan Ahm, 来源:中德临床肿瘤学杂志:英文版 年份:2013
目的几试用建议了并发的 chemoradiotherapy 的优势。这被假设了全身的剂量的增加作为正式就职或作为巩固,到并发的 chemoradiotherapy 的顺序的化疗可能进一步改进幸存率。我...
[期刊论文] 作者:Hend Ahmed EI-Hadaad,Hanan AHM, 来源:临床肿瘤与癌症研究(英文版) 年份:2004
OBJECTIVE Promising anti-tumor activity in patients with metastatic or unresectable soft tissue sarcomas has been reported with gemcitabine and/or docetaxel.MET...
[期刊论文] 作者:Hend Ahmed El-Hadaad,Hanan Ahm, 来源:中德临床肿瘤学杂志(英文版) 年份:2004
[期刊论文] 作者:Hend Ahmed El-Hadaad,Hanan Ahm, 来源:癌症生物学与医学(英文版 ) 年份:2012
Objective To explore if the addition of adjuvant chemotherapy with paclitaxel and carboplatin to radiotherapy confers an advantage for overall survival (OAS), a...
相关搜索: